Carlos Fernandez-Pereira, MD

Oral Rapamycin in the Treatment of Diffuse Proliferative In-Stent Restenosis in a Patient with Small Reference Vessel

08/01/2008

Case Report. A 63-year-old man was admitted to our hospital due to recent onset chest pain with radiation to the left arm, which was precipitated by minimum efforts and relieved by rest. He was evaluated at the coronary care unit and treated...

Case Report. A 63-year-old man...

08/01/2008

Journal of Invasive Cardiology

Pilot Study of Oral Rapamycin to Prevent Restenosis in Patients Undergoing Coronary Stent Therapy: Argentina Single-Center Study

08/01/2008

Miguel Russo , MD;

John A. Ambrose , MD;

Claudio Llaurado , BS;

Carlos Fernandez-Pereira , MD;

Alfredo E. Rodriguez , MD, PhD;

Renu Virmani , MD, PhD;

Maximo Rodriguez Alemparte , MD;

Cesar F. Vigo , MD;

Observational and randomized studies recently showed that sirolimus-coated stents were associated with a lower rate of restenosis than bare stents.1–3 Although the restenosis rate was lower, coated stents have a significantly higher cost than...

Observational and randomized...

08/01/2008

Journal of Invasive Cardiology

Case Report

Late Stent Thrombosis Mimicking Focal Restenosis after Sirolimus Stent Implantation: Angiographic and Intravascular Ultrasound A

08/01/2008

Gaston A. Alfredo Rodriguez-Granillo , MD;

Carlos Fernandez-Pereira , MD;

Alfredo E. Rodriguez , MD, PhD;

Since the introduction of drug-eluting stents (DES) during interventional procedures, several randomized studies have demonstrated a significant reduction in coronary restenosis and target vessel revascularizations.1–4 However, despite the...

Since the introduction of...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

New Coating Stent Design for Patients with High-Risk Coronary Lesions for Thrombotic Events: (Full title below)

08/17/2009

Gilberto Perez , MD;

Alfredo M. Rodriguez-Granillo , BS;

Juan Mieres , MD;

Claudio Llaurado , BS;

Bibiana Rubilar , MD;

Gustavo Risau , MD;

Carlos Fernandez-Pereira , MD;

Alfredo E. Rodriguez , MD, PhD;

ABSTRACT: Background. Semisynthetic coating of the Camouflage bare-metal stent (BMS) (Eucatech AG, Rheinfelden, Germany) mimics luminal endothelial cell glycocalix, potentially preventing the activation of the coagulation system. Purpose. We...

ABSTRACT: Background....

08/17/2009

Journal of Invasive Cardiology